Spyre Therapeutics Announces Topline Results from the Rheumatoid Arthritis Sub-study of the SKYWAY Phase 2 Trial of SPY072
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| (NASDAQ: SYRE) | Delayed: 92.85 +1.45 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.40 | 52 Week High | $ | |||
| Open | $92.78 | 52 Week Low | $ | |||
| Day High | $95.17 | P/E | N/A | |||
| Day Low | $92.32 | EPS | $ | |||
| Volume | 344,648 | |||||
